IP Library › Granted Patent US 11,162,117
Granted Patent B2
US 11,162,117 · App. 16/192,207 · Granted Nov 2, 2021

Whole-cell catalytic system and applications thereof

Inventors: Kung-Ta Lee (Taipei, TW); Shan-Chi Hsieh (Taipei, TW); Ching-Yeuh Su (Taipei, TW); Yu-Chen Lai (Taipei, TW)
Assignee: NATIONAL TAIWAN UNIVERSITY
C12P7/6436C07K14/21C07K14/79C12N1/205C12Y118/01002C12R2001/01C12Y114/15003
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,162,117
App. No.
16/192,207
Granted
Nov 2, 2021
Kind
B2
Abstract

Provided is a method of activating gene expression using a protein having 90% or more sequence identity to SEQ ID NO:45. The protein activates the expression of a gene upon induction with a medium-chain or long-chain alkane or a medium-chain or long-chain fatty acid methyl ester. Also provided is a whole-cell catalytic system regulated by a medium-chain or long-chain alkane or a medium-chain or long-chain fatty acid methyl ester. The system includes a recombinant microbial cell expressing the protein and an alkane monooxygenase. Also provided is a method of preparing a medium-chain or long-chain alkane terminal oxidation product using the whole-cell catalytic system.

Claims (23)

1. A method of activating gene expression, comprising a step of contacting a recombinant microbial cell with a medium-chain or long-chain alkane or a medium-chain or long-chain fatty acid methyl ester;

wherein the recombinant microbial cell expresses a protein having 90% or more sequence identity to SEQ ID NO:45 and comprises a gene for activated expression;

wherein the recombinant microbial cell further expresses an alkane transporter and an alkane monooxygenase;

wherein the alkane monooxygenase is a cytochrome P450, the cytochrome P450 consists of a CYP153A, a ferredoxin, and a ferredoxin reductase;

wherein the CYP153A, the ferredoxin, and the ferredoxin reductase are derived from Marinobacter aquaeoli VT8, the CYP153A is reconstructed to exclude a transposon at a position corresponding to an amino terminus of the ferredoxin; and

wherein the alkane transporter is an AlkL protein derived from Pseudomonas putida , and the gene expression is activated without adding isopropyl β-D-1-thiogalactopyranoside (IPTG) or dicyclopropylketone (DCPK) as an inducer.

2. The method of claim 1 , wherein the medium-chain or long-chain alkane is a straight-chain alkane having a carbon chain length of C8 or greater.

3. The method of claim 1 , wherein the medium-chain or long-chain fatty acid methyl ester is a straight-chain saturated fatty acid methyl ester having a carbon chain length of C8 or greater.

4. The method of claim 3 , wherein the straight-chain saturated fatty acid methyl ester is methyl laurate.

5. The method of claim 1 , wherein the gene encodes a cytochrome P450.

6. A whole-cell catalytic system regulated by a medium-chain or long-chain alkane or a medium-chain or long-chain fatty acid methyl ester, comprising a recombinant microbial cell expressing a protein having 90% or more sequence identity to SEQ ID NO:45 and an alkane monooxygenase;

wherein the recombinant microbial cell further expresses an alkane transporter, the alkane transporter is an AlkL protein derived from Pseudomonas putida , and the whole-cell catalytic system is regulated without adding isopropyl β-D-1-thiogalactopyranoside (IPTG) or dicyclopropylketone (DCPK) as an inducer; and

wherein the alkane monooxygenase is a cytochrome P450, the cytochrome P450 consists of a CYP153A, a ferredoxin, and a ferredoxin reductase, the CYP153A, the ferredoxin, and the ferredoxin reductase are derived from Marinobacter aquaeoli VT8, and the CYP153A is reconstructed to exclude a transposon at a position corresponding to an amino terminus of the ferredoxin.

7. A method of preparing a medium-chain or long-chain alkane terminal oxidation product, comprising the following steps of:

(a) providing a recombinant microorganism, comprising a first gene encoding an alkane monooxygenase, and a second gene encoding a protein having 90% or more sequence identity to SEQ ID NO:45;

(b) incubating the recombinant microorganism in a culture medium containing a carbon source; and

(c) adding a medium-chain or long-chain alkane or a medium-chain or long-chain fatty acid methyl ester to the culture medium for a predetermined period of time to obtain the medium-chain or long-chain alkane terminal oxidation product, wherein the recombinant microorganism further comprises a gene encoding an alkane transporter, the alkane transporter is an AlkL protein derived from Pseudomonas putida , and the medium-chain or long-chain alkane terminal oxidation product is prepared without adding isopropyl β-D-1-thiogalactopyranoside (IPTG) or dicyclopropylketone (DCPK) as an inducer;

wherein the alkane monooxygenase is a cytochrome P450, the cytochrome P450 consists of a CYP153A, a ferredoxin, and a ferredoxin reductase, the CYP153A, the ferredoxin, and the ferredoxin reductase are derived from Marinobacter aquaeoli VT8, and the CYP153A is reconstructed to exclude a transposon at a position corresponding to an amino terminus of the ferredoxin.

8. The method of claim 7 , wherein the medium-chain or long-chain alkane is a straight-chain alkane having a carbon chain length of C8 or greater.

9. The method of claim 7 , wherein the medium-chain or long-chain fatty acid methyl ester is a straight-chain saturated fatty acid methyl ester having a carbon chain length of C8 or greater.

10. The method of claim 9 , wherein the straight-chain saturated fatty acid methyl ester having a carbon chain length is methyl laurate.

11. The method of claim 7 , wherein the medium-chain or long-chain alkane terminal oxidation product is an alkanol, an alkanediol, an alkanoic acid, an alkane dioic acid, a dicarboxylic acid methyl ester, an alcohol acid, or an alcohol amine having a carbon chain length of C8 or greater.

12. The method of claim 7 , wherein the expression of the alkane transporter is regulated by rhamnose.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2018
From: LEE, KUNG-TA; HSIEH, SHAN-CHI; SU, CHING-YEUH; LAI, YU-CHEN
To: NATIONAL TAIWAN UNIVERSITY
Reel/Frame 048104/0498 →
Priority Claims (1)
TW 107109303 · Mar 19, 2018 · national
Continuity (1)
Related Publication 20190284589A1 · Sep 19, 2019